- Home
- NVRI vs IMNM Comparison
NVRI vs IMNM Comparison
Compare NVRI & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- IMNM
- Stock Information
- Founded
- NVRI 1853
- IMNM 2006
- Country
- NVRI United States
- IMNM United States
- Employees
- NVRI N/A
- IMNM N/A
- Industry
- NVRI Diversified Commercial Services
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- NVRI Miscellaneous
- IMNM Health Care
- Exchange
- NVRI Nasdaq
- IMNM Nasdaq
- Market Cap
- NVRI 521.3M
- IMNM 617.3M
- IPO Year
- NVRI N/A
- IMNM 2020
- Fundamental
- Price
- NVRI $6.13
- IMNM $8.50
- Analyst Decision
- NVRI Hold
- IMNM Strong Buy
- Analyst Count
- NVRI 1
- IMNM 6
- Target Price
- NVRI $10.00
- IMNM $26.00
- AVG Volume (30 Days)
- NVRI 797.3K
- IMNM 1.5M
- Earning Date
- NVRI 05-01-2025
- IMNM 05-13-2025
- Dividend Yield
- NVRI N/A
- IMNM N/A
- EPS Growth
- NVRI N/A
- IMNM N/A
- EPS
- NVRI N/A
- IMNM N/A
- Revenue
- NVRI $2,342,645,000.00
- IMNM $9,041,000.00
- Revenue This Year
- NVRI N/A
- IMNM N/A
- Revenue Next Year
- NVRI $3.60
- IMNM $1,259.12
- P/E Ratio
- NVRI N/A
- IMNM N/A
- Revenue Growth
- NVRI N/A
- IMNM N/A
- 52 Week Low
- NVRI $4.72
- IMNM $5.15
- 52 Week High
- NVRI $12.79
- IMNM $19.07
- Technical
- Relative Strength Index (RSI)
- NVRI 49.33
- IMNM 60.76
- Support Level
- NVRI $5.59
- IMNM $6.96
- Resistance Level
- NVRI $5.95
- IMNM $8.40
- Average True Range (ATR)
- NVRI 0.46
- IMNM 0.66
- MACD
- NVRI 0.08
- IMNM 0.33
- Stochastic Oscillator
- NVRI 75.95
- IMNM 92.54
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.